GeneBioTech Co. ,Ltd (KOSDAQ:086060)

GeneBioTech Co. ,Ltd Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	89,438	90,789	82,959	79,477	82,759	62,814
Revenue Growth	4.42%	9.44%	4.38%	-3.96%	31.75%	6.25%
Gross Profit Gross Profit Growth	14,538	14,256	13,370	13,652	10,349	7,439
Operating Income Operating Income Growth	4,008	3,996	3,844	3,973	1,557	-453.15
Net Income Net Income Growth	3,589	3,789	2,865	2,591	1,523	-484.4
Earnings Per Share EPS Growth	416.61	440.02	333.00	300.95	176.91	-56.26
EPS Growth	22.18%	32.14%	10.65%	70.12%	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	26,501	24,897	23,404	22,016	16,090	17,790
Total Debt Total Debt Growth	16,432	14,957	15,885	12,502	13,029	10,302
Net Cash (Debt) Net Cash Growth	10,069	9,940	7,519	9,514	3,061	7,488
Net Cash Growth	50.94%	32.20%	-20.97%	210.80%	-59.12%	-65.62%
Net Cash Per Share Net Cash Per Share Growth	1168.91	1154.38	873.87	1104.91	355.50	869.68

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	6,308	7,614	-463.87	7,369	-3,679	-2,713
Capital Expenditures CapEx Growth	-3,264	-3,758	-1,100	-530.02	-1,155	-3,102
Free Cash Flow Free Cash Flow Growth	3,044	3,856	-1,564	6,838	-4,834	-5,816
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	16.25%	15.70%	16.12%	17.18%	12.50%	11.84%
Operating Margin	4.48%	4.40%	4.63%	5.00%	1.88%	-0.72%
Pretax Margin	4.70%	4.86%	4.22%	4.25%	2.19%	-1.33%
Profit Margin	4.01%	4.17%	3.45%	3.26%	1.84%	-0.77%
FCF Margin	3.40%	4.25%	-1.89%	8.60%	-5.84%	-9.26%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	50.000	-	-	-	-	-
Dividend Per Share Growth	0%	-	-	-	-	-
Dividend Yield	1.01%	-	-	-	-	-

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	11.88	9.11	9.89	14.49	22.55	-
P/FCF Ratio	14.00	8.95	-	5.49	-	-
PS Ratio	0.48	0.38	0.34	0.47	0.42	0.72

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error